Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder
收藏官方服务：
资源简介：
Excel spreadsheet
应用场景：
创建时间：
2019-12-10
相关数据集
Middle East and Africa Medication-Assisted Treatment (MAT) Market – Industry Trends and Forecast to 2029
Middle East and Africa Medication-Assisted Treatment (MAT) Market, By Type (Medication and Therapy), Products (Buprenorphine and Naloxone, Naltrexone, Buprenorphine, Methadone, Naloxone, Disulfiram an
www.databridgemarketresearch.com60
Baseline socio-demographic and clinical characteristics among people receiving medication-assisted treatment for substance use disorder in Dar es Salaam, Tanzania (N = 901).
Baseline socio-demographic and clinical characteristics among people receiving medication-assisted treatment for substance use disorder in Dar es Salaam, Tanzania (N = 901).
NIAID Data Ecosystem30
Implications of Epidemic-Pandemic Convergences for Routine Care Adoption of Contingency Management: A Case Study
To bridge the gap between opioid overdoses and treatment entry a smartphone-smart debit card contingency management program was developed to promote entry into medication-assisted treatment by out-of-
Mendeley Data2024-03-27 更新20
Changing nurse practitioner students’ perceptions regarding substance use disorder
Nurse practitioners, like other healthcare professionals, are serving an increased number of individuals and families affected by substance use disorder (SUD), in a variety of healthcare settings. Th
NIAID Data Ecosystem40
Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression
Background: Opioid use disorder (OUD) is a chronic relapsing condition with a high mortality rate. While medications such as methadone are valuable first-line therapies, retention is poor, with
Taylor & Francis Group2025-11-26 更新20
